or Try an Advanced Search...

    Technical Analysis for MYMD - MyMD Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    D 2.84 1.07% 0.03
    MYMD closed up 1.07 percent on Friday, April 26, 2024, on 6 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
    Earnings due: May 13
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Flat Up
    Historical MYMD trend table...
    Date Alert Name Type % Chg
    Crossed Above 50 DMA Bullish 0.00%
    Wide Bands Range Expansion 0.00%
    Narrow Range Bar Range Contraction 1.07%
    Inside Day Range Contraction 1.07%
    Wide Bands Range Expansion 1.07%
    50 DMA Resistance Bearish -0.70%
    Outside Day Range Expansion -0.70%
    Wide Bands Range Expansion -0.70%
    Above Upper BB Strength -0.70%
    Upper Bollinger Band Touch Strength -0.70%
    Older End-of-Day Signals for MYMD ...

       Recent Intraday Alerts

    Alert Time
    50 DMA Resistance about 7 hours ago
    Upper Bollinger Band Resistance about 7 hours ago
    60 Minute Opening Range Breakout about 7 hours ago
    Rose Above Previous Day's High about 7 hours ago
    Rose Above 50 DMA about 7 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    MYMD Chart by TradingView
    Basic chart:

    Profile

    MyMD Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the development of drug products in the targeting of aging and age-related diseases; autoimmune diseases; and chronic pain, anxiety, and sleep disorders. It commercializes MYMD-1, a novel therapeutic to impact conditions related to immunometabolic dysregulation; and SUPERA-1R, a synthetic cannabidiol that offers bioavailability and potency than botanicals. The company was incorporated in 2014 and is based in Tampa, Florida.
    Classification
    Sector: Healthcare
    Industry: Medical Instruments & Supplies
    Keywords: Medicine Pharmaceutical Immunology Health Sciences Autoimmune Disease Medication Health Care Cannabis Disorders Euphoriants Chronic Pain Entheogens Autoimmunity Drug Products Cannabidiol Age Related Diseases Appetite Stimulants

    Is MYMD a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 9 Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Apr 9 Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket
    Mar 5 MyMD Pharmaceuticals said it has regained compliance with Nasdaq rules
    Mar 5 MyMD Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing
    Feb 13 MyMD Pharmaceuticals down after announcing reverse stock split
    Feb 13 MyMD Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing
    Jan 17 Why DatChat Shares Are Trading Lower By Around 33%; Here Are 20 Stocks Moving Premarket
    Dec 29 MyMD Pharmaceuticals Releases Positive Clinical Trial Results For Sarcopenia Treatment Drug
    Dec 13 Why ReShape Lifesciences Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
    Dec 6 MyMD Pharmaceuticals Plans FDA-Cleared Phase 2 Clinical Trial of MYMD-1 in Rheumatoid Arthritis
    See more MYMD news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 70.5
    52 Week Low 2.0
    Average Volume 270,674
    200-Day Moving Average 13.14
    50-Day Moving Average 2.84
    20-Day Moving Average 2.46
    10-Day Moving Average 2.53
    Average True Range 0.25
    RSI (14) 56.52
    ADX 27.71
    +DI 36.00
    -DI 17.17
    Chandelier Exit (Long, 3 ATRs) 2.76
    Chandelier Exit (Short, 3 ATRs) 2.74
    Upper Bollinger Bands 2.93
    Lower Bollinger Band 1.98
    Percent B (%b) 0.9
    BandWidth 38.84
    MACD Line -0.04
    MACD Signal Line -0.14
    MACD Histogram 0.0998
    Fundamentals Value
    Market Cap 144.56 Million
    Num Shares 50.9 Million
    EPS -0.17
    Price-to-Earnings (P/E) Ratio -16.71
    Price-to-Sales 0.00
    Price-to-Book 0.47
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.05
    Resistance 3 (R3) 3.04 2.96 3.02
    Resistance 2 (R2) 2.96 2.91 2.97 3.00
    Resistance 1 (R1) 2.90 2.87 2.93 2.91 2.99
    Pivot Point 2.82 2.82 2.84 2.83 2.82
    Support 1 (S1) 2.76 2.77 2.79 2.77 2.69
    Support 2 (S2) 2.68 2.73 2.69 2.68
    Support 3 (S3) 2.62 2.68 2.67
    Support 4 (S4) 2.63